• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Onset Symptoms, Tobacco Smoking, and Progressive-Onset Phenotype Are Associated With a Delayed Onset of Multiple Sclerosis, and Marijuana Use With an Earlier Onset.起病症状、吸烟与渐进性起病表型与多发性硬化症的延迟发病相关,而使用大麻则与较早发病相关。
Front Neurol. 2018 Jun 8;9:418. doi: 10.3389/fneur.2018.00418. eCollection 2018.
2
The physical anthropometry, lifestyle habits and blood pressure of people presenting with a first clinical demyelinating event compared to controls: the Ausimmune study.首发临床脱髓鞘事件患者与对照者的人体测量学、生活方式习惯和血压比较:Ausimmune 研究。
Mult Scler. 2013 Nov;19(13):1717-25. doi: 10.1177/1352458513483887. Epub 2013 May 13.
3
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.高纬度与多发性硬化症的发病年龄较早显著相关。
J Neurol Neurosurg Psychiatry. 2016 Dec;87(12):1343-1349. doi: 10.1136/jnnp-2016-314013. Epub 2016 Nov 3.
4
Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis.多发性硬化症、视神经脊髓炎和横贯性脊髓炎的危险因素。
Mult Scler. 2015 May;21(6):703-9. doi: 10.1177/1352458514551780. Epub 2014 Oct 10.
5
The use of satellite data to measure ultraviolet-B penetrance and its potential association with age of multiple sclerosis onset.利用卫星数据测量紫外线-B 的穿透力及其与多发性硬化症发病年龄的潜在关联。
Mult Scler Relat Disord. 2018 Apr;21:30-34. doi: 10.1016/j.msard.2018.02.005. Epub 2018 Feb 6.
6
The relationship between early age of onset of initial substance use and engaging in multiple health risk behaviors among young adolescents.青少年初次使用物质的早期发病年龄与从事多种健康风险行为之间的关系。
Arch Pediatr Adolesc Med. 1999 Mar;153(3):286-91. doi: 10.1001/archpedi.153.3.286.
7
Multiple sclerosis risk factors contribute to onset heterogeneity.多发性硬化症的风险因素导致发病异质性。
Mult Scler Relat Disord. 2019 Feb;28:11-16. doi: 10.1016/j.msard.2018.12.007. Epub 2018 Dec 4.
8
Patient-reported outcomes are worse for progressive-onset multiple sclerosis than relapse-onset multiple sclerosis, particularly early in the disease process.与复发缓解型多发性硬化相比,进行性多发性硬化患者的报告结局更差,尤其是在疾病早期。
Eur J Neurol. 2019 Jan;26(1):155-161. doi: 10.1111/ene.13786. Epub 2018 Sep 24.
9
Complex relation of HLA-DRB1*1501, age at menarche, and age at multiple sclerosis onset.HLA-DRB1*1501 与初潮年龄和多发性硬化症发病年龄的复杂关系。
Neurol Genet. 2016 Jul 26;2(4):e88. doi: 10.1212/NXG.0000000000000088. eCollection 2016 Aug.
10
Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis.炎症与进展性多发性硬化患者残疾累积的相关性。
JAMA Neurol. 2018 Nov 1;75(11):1407-1415. doi: 10.1001/jamaneurol.2018.2109.

引用本文的文献

1
Seasonal variability of serum 25-hydroxyvitamin D on multiple sclerosis onset.多发性硬化症发病时血清 25-羟维生素 D 的季节性变化。
Sci Rep. 2021 Oct 25;11(1):20989. doi: 10.1038/s41598-021-00344-0.
2
Onset Symptom Clusters in Multiple Sclerosis: Characteristics, Comorbidities, and Risk Factors.多发性硬化症的起病症状群:特征、合并症及危险因素
Front Neurol. 2021 Jul 6;12:693440. doi: 10.3389/fneur.2021.693440. eCollection 2021.
3
Modifiable risk factors for poor health outcomes in multiple sclerosis: The urgent need for research to maximise smoking cessation success.多发性硬化症不良健康结局的可改变风险因素:急需研究以最大程度提高戒烟成功率。
Mult Scler. 2020 Mar;26(3):266-271. doi: 10.1177/1352458519858730. Epub 2019 Jun 20.

本文引用的文献

1
The age at onset in Multiple Sclerosis is associated with patient's prognosis.多发性硬化症的发病年龄与患者的预后相关。
Bratisl Lek Listy. 2017;118(6):374-377. doi: 10.4149/BLL_2017_071.
2
Association between human herpesvirus & human endogenous retrovirus and MS onset & progression.人类疱疹病毒与人类内源性逆转录病毒之间的关联以及多发性硬化症的发病与进展。
J Neurol Sci. 2017 Jan 15;372:239-249. doi: 10.1016/j.jns.2016.11.060. Epub 2016 Nov 24.
3
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.高纬度与多发性硬化症的发病年龄较早显著相关。
J Neurol Neurosurg Psychiatry. 2016 Dec;87(12):1343-1349. doi: 10.1136/jnnp-2016-314013. Epub 2016 Nov 3.
4
Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.遗传易感性变异在多发性硬化症临床病程预测中的作用:一项队列研究。
J Neurol Neurosurg Psychiatry. 2016 Nov;87(11):1204-1211. doi: 10.1136/jnnp-2016-313722. Epub 2016 Aug 24.
5
Association between age at onset of multiple sclerosis and vitamin D level-related factors.多发性硬化症发病年龄与维生素D水平相关因素之间的关联。
Neurology. 2016 Jan 5;86(1):88-93. doi: 10.1212/WNL.0000000000002075. Epub 2015 Oct 7.
6
Class II HLA interactions modulate genetic risk for multiple sclerosis.II类人类白细胞抗原相互作用调节多发性硬化症的遗传风险。
Nat Genet. 2015 Oct;47(10):1107-1113. doi: 10.1038/ng.3395. Epub 2015 Sep 7.
7
Associations between onset age and disability in multiple sclerosis patients studied using MSSS and a progression model.使用多发性硬化症严重程度评分(MSSS)和一种进展模型对多发性硬化症患者的发病年龄与残疾之间的关联进行研究。
Mult Scler Relat Disord. 2014 Sep;3(5):593-9. doi: 10.1016/j.msard.2014.06.002. Epub 2014 Jun 24.
8
Population attributable fractions and joint effects of key risk factors for multiple sclerosis.多发性硬化关键危险因素的人群归因分数及联合效应
Mult Scler. 2016 Apr;22(4):461-9. doi: 10.1177/1352458515594040. Epub 2015 Jul 21.
9
Effects of cannabis on cognition in patients with MS: a psychometric and MRI study.大麻对多发性硬化症患者认知功能的影响:一项心理测量和核磁共振成像研究。
Neurology. 2014 May 27;82(21):1879-87. doi: 10.1212/WNL.0000000000000446. Epub 2014 Apr 30.
10
Smoking and multiple sclerosis susceptibility.吸烟与多发性硬化易感性。
Eur J Epidemiol. 2013 Nov;28(11):867-74. doi: 10.1007/s10654-013-9853-4. Epub 2013 Oct 22.

起病症状、吸烟与渐进性起病表型与多发性硬化症的延迟发病相关,而使用大麻则与较早发病相关。

Onset Symptoms, Tobacco Smoking, and Progressive-Onset Phenotype Are Associated With a Delayed Onset of Multiple Sclerosis, and Marijuana Use With an Earlier Onset.

作者信息

Tao Chunrong, Simpson Steve, Taylor Bruce V, Blizzard Leigh, Lucas Robyn M, Ponsonby Anne-Louise, Broadley Simon, van der Mei Ingrid

机构信息

Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.

Institute for Health & Ageing, Australian Catholic University, Melbourne, VIC, Australia.

出版信息

Front Neurol. 2018 Jun 8;9:418. doi: 10.3389/fneur.2018.00418. eCollection 2018.

DOI:10.3389/fneur.2018.00418
PMID:29937751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6003245/
Abstract

Age at symptom onset (ASO) is a prognostic factor that could affect the accrual of disability in multiple sclerosis (MS) patients. Some factors are known to influence the risk of multiple sclerosis (MS), but their influence on the ASO is less well-investigated. Examine the associations between known or emerging MS risk factors and ASO. This was a multicenter study, incident cases ( = 279) with first clinical diagnosis of demyelinating event aged 18-59 years recruited at four Australian centres (latitudes 27°-43°S), from 1 November 2003 to 31 December 2006. Environmental/behavioral variables and initial symptoms were recorded at baseline interview. Linear regression was used to assess the association between risk factors and ASO. Five factors were significantly associated with ASO: a history of tobacco smoking was associated with 3.05-years later ASO ( = 0.002); a history of marijuana use was associated with 6.03-years earlier ASO ( < 0.001); progressive-onset cases had 5.61-years later ASO ( = 0.001); an initial presentation of bowel & bladder and cerebral dysfunctional were associated with 3.39 ( = 0.017) and 4.37-years ( = 0.006) later ASO, respectively. Other factors, including sex, offspring number, latitude of study site, history of infectious mononucleosis, genotype, 25(OH)D levels, and ultraviolet radiation exposure were not associated with ASO. Including all five significant variables into one model explained 12% of the total variance in ASO. We found a novel association between a history of tobacco smoking and later onset, whereas marijuana use was associated with earlier onset. Behavioral factors seem important drivers of MS onset timing although much of the variance remains unexplained.

摘要

症状出现年龄(ASO)是一个预后因素,可能会影响多发性硬化症(MS)患者残疾的累积。已知一些因素会影响多发性硬化症(MS)的风险,但它们对ASO的影响研究较少。研究已知或新出现的MS风险因素与ASO之间的关联。这是一项多中心研究,从2003年11月1日至2006年12月31日,在澳大利亚四个中心(南纬27°-43°)招募了年龄在18-59岁之间、首次临床诊断为脱髓鞘事件的279例新发病例。在基线访谈时记录环境/行为变量和初始症状。采用线性回归评估风险因素与ASO之间的关联。有五个因素与ASO显著相关:吸烟史与ASO延迟3.05年相关(P=0.002);使用大麻史与ASO提前6.03年相关(P<0.001);渐进性起病病例的ASO延迟5.61年(P=0.001);肠道和膀胱及脑功能障碍的初始表现分别与ASO延迟3.39年(P=0.017)和4.37年(P=0.006)相关。其他因素,包括性别、子女数量、研究地点的纬度、传染性单核细胞增多症病史、基因型、25(OH)D水平和紫外线辐射暴露与ASO无关。将所有五个显著变量纳入一个模型可解释ASO总方差的12%。我们发现吸烟史与发病延迟之间存在新的关联,而使用大麻与发病提前相关。行为因素似乎是MS发病时间的重要驱动因素,尽管大部分方差仍无法解释。